COVID-19 in heart transplant recipients

Taghavi, Sepideh and Raffiei Jelodar, Hoda and Rafati, Ali and Naderi, Nasim and Mirtajaddini, Marzieh and Amin, Ahmad and Valizadeh, Leili and Omidvar, Razieh and Kamali, Monireh and Naseh, Soroush (2022) COVID-19 in heart transplant recipients. Journal of Cardiovascular and Thoracic Research, 14 (4). pp. 258-262. ISSN 2008-5117

Text
jcvtr-14-258.pdf - Published Version
Download (257kB)

Official URL: https://doi.org/10.34172/jcvtr.2022.31583

Abstract

Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19.

Methods: We enrolled twenty-two COVID-19 cases of adult heart transplantation from February 2020 to September 2021.

Results: The most common symptoms in patients were fever and myalgia. The death occurred in 3 (13.6 %).

Conclusion: Although heart transplantation mortality may increase in the acute rejection phase concomitant with COVID-19, immunosuppressive dose reduction may not be necessary for all heart transplant patients with COVID-19.

Item Type:	Article
Subjects:	Pustakas > Medical Science
Depositing User:	Unnamed user with email support@pustakas.com
Date Deposited:	23 May 2023 07:34
Last Modified:	06 Feb 2024 04:31
URI:	http://archive.pcbmb.org/id/eprint/480

Actions (login required)

: View Item